Fremed SRL
Fremed reported total assets of 21,724 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Mar 2026).
The score of Fremed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +39 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Fremed's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Mar 2026
- Year ended 31 Dec 2024filed on 25 Mar 2026
- Year ended 31 Dec 2023filed on 23 Mar 2026
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
Fremed's financial analysis
- Solvency-105.7%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Fremed
Fremed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0419.037.822
- VAT number
- BE0419037822
- Peppol
- Registered · 0208:0419037822 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Dec 1978
- Registered office
- 8500 Kortrijk
- Latest accounts
- 2025 · filed on 26 Mar 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Fremed (SRL) has been based in Kortrijk since 1978, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 4,495 € and equity of −22,959 €; its revenue is not published. Its solvency stands at -105.7%, below the median of its sector (46.0%).
Companies similar to Fremed
Companies in the same business, of comparable size and area, outside its group.
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Bvpm Distribution Andenne · balance sheet 20,739 €
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
- MiniMed Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet 8,076 €
- Gyntech Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 20,358 €
Frequently asked questions about Fremed
What is the revenue of Fremed?
Fremed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Fremed?
In Belgium, the VAT number is the company number prefixed with BE: BE0419037822 for Fremed, if the company is VAT-registered. Its company number (CBE) is 0419.037.822.
Where is the registered office of Fremed?
According to the CBE register, the registered office of Fremed is in 8500 Kortrijk.
What is the equity of Fremed?
At the close of the 2025 financial year, the equity of Fremed amounts to -22,959 €, a solvency of -105.7% of total assets.
Who manages Fremed?
The register lists 1 active mandates at Fremed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Fremed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →